BASF to Acquire Dutch Polyurethane Manufacturer

BASF Group company Elastogran plans to purchase the Dutch Polyurethane System House Polymer Chemical Company B.V. (PCC). An agreement finalizing the planned acquisition was signed by both parties on February 15, 2007. The transaction will be completed subject to the permission of the Monopoly and Merger Commission. The parties mutually agreed not to disclose the purchase price.

“With the takeover of this successful system house we will effectively strengthen our position in the attractive Benelux market as well as our position as market leader for polyurethane systems in Europe,“ said Dr. Uwe Hartwig, member of the Elastogran management board. “The performance of PCC fits perfectly with our European network of 11 polyurethane system houses to date, all of which operate close to their customers. As a consequence of this acquisition we will further intensify existing customer relationships and continue with the development of customer-oriented polyurethane systems and technologies.“

PCC was founded in 1976 and has since been operating as an independent system house mainly for polyurethane rigid foam systems and spray coatings. PCC employs approximately 30 staff and has a 10,000 sqm plant in Boxtel, near Tilburg. Following the conclusion of the planned acquisition PCC is to be integrated into the Elastogran Group as a subsidiary under the name “Elastogran BeNeLux B.V.”

Polyurethanes are versatile plastics for a wide range of applications. The properties of the material can be tailored to suit all needs. Polyurethane products are employed in the automobile industry, for thermal insulation in construction work both above and below ground, in cooling technology, electronics, shoes and furniture manufacturing as well as sports and leisure equipment.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.